top banner image  

topleft corner image     top right corner image
 


bullet

JACC Homepage JACC Imaging Homepage
Still not a subscriber to JACC Imaging or JACC Interventions?

     top nav image

     

J Am Coll Cardiol Intv, 2008; 1:595, doi:10.1016/j.jcin.2008.08.006
© 2008 by the American College of Cardiology Foundation
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jabara, R.
Right arrow Articles by Robinson, K.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Jabara, R.
Right arrow Articles by Robinson, K.
Related Collections
Right arrowRelated Article

Letter to the Editor

Reply

Refat Jabara, MD*, Jinsheng Li, MD, PhD, Keith Robinson, PhD, FACC


The observations of Dr. Kaneda and colleagues are clearly pertinent to the issues we raised in the Discussion section of our article (1). A common hypothesis generated by both of our results seems to be whether long-term (1 month post-implantation of sirolimus-eluting stents [SES] and even later) vasomotor dysfunction might be caused by a direct effect of the drug itself at very low concentration or secondary effects mediated through SES-triggered cellular interactions (for example, chronic SES-induced inflammation in the stented segment elaborating cytokines or other substances that impact endothelium-dependent relaxation). We suggest that the data currently available are inconclusive, because neither of these possibilities can yet be ruled out. Of interest however is that Jabs et al. (2) recently reported increased superoxide and p67(phox)/rac1 nicotinamide adenosine dinucleotide phosphate oxidase and reduced nitric oxide, along with vasomotor dysfunction, in the aortas of rats given a 1-week continuous infusion of sirolimus. Their report did not include a histological assessment, but the recruitment of inflammatory cells would seem to be a plausible potential mechanism underlying these phenomena.

* Saint Joseph's Cardiovascular Research Institute/Saint Joseph's Hospital of Atlanta, 5673 Peachtree Dunwoody Road, Suite 675, Atlanta, Georgia 30342 (Email: rjabara{at}sjha.org).


    REFERENCES
 Top
 REFERENCES
 

  1. Li J, Jabara R, Pendyala R, et al. Abnormal vasomotor function of porcine coronary arteries distal to sirolimus-eluting stents J Am Coll Cardiol Intv 2008;1:279-285.[Abstract/Free Full Text]
  2. Jabs A, Göbel S, Wenzel P, et al. Sirolimus-induced vascular dysfunction. Increased mitochondrial and nicotinamide adenosine dinucleotide phosphate oxidase-dependent superoxide production and decreased vascular nitric oxide formation. J Am Coll Cardiol 2008;51:2130-2138.[Abstract/Free Full Text]

Related Article

Tissue Sirolimus Levels of Distal Vessel, Stented Myocardium, and Distal Myocardium
Hideaki Kaneda, Alan Yeung, and Fumiaki Ikeno
J. Am. Coll. Cardiol. Intv. 2008 1: 595. [Full Text] [PDF]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jabara, R.
Right arrow Articles by Robinson, K.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Jabara, R.
Right arrow Articles by Robinson, K.
Related Collections
Right arrowRelated Article

 
   
 
home link current link search link archive link topics link cardiology careers link